Bacillus subtilis strain with strong inhibition of enteropathogenic and foodborne pathogenic bacteria
Bacillus subtilis strain PS-216 has been shown to have strong inhibitory activity against enteropathogenic and/or foodborne pathogenic bacteria, such as Campylobacter jejuni. Particularly, our innovative product uses the Bacillus subtilis strain PS-216 for the preparation of food compositions and probiotic compositions.
Nitroxoline for prevention and treatment of coronavirus disease
The advantage of nitroxoline over other candidate drugs for the treatment of Covid 19 (repurposing drugs - amantadine, teicoplanin) is that the mechanism of action on the target is precisely defined, since years ago we determined the spatial structure of the complex with cathepsin B.